Estrogen-induced cardiorenal protection: Potential cellular, biochemical, and molecular mechanisms

American Journal of Physiology - Renal Physiology

Volumn 280, Issue 3 49-3, 2001, Pages

  Dubey, Raghvendra K ^a,b   Jackson, Edwin K ^a,c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Antimitogenic; Endothelial cells; Estradiol; Growth factors; Hyperplasia; Menopause; Mesangial cells; Metabolism; Methoxyestradiol; Smooth muscle cells

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR;

BLOOD VESSEL TONE; ESTROGEN THERAPY; HEART PROTECTION; HEART VENTRICLE REMODELING; HORMONE ACTION; HUMAN; HUMAN CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENAL PROTECTION; REVIEW;

EID: 0034990298     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.2001.280.3.f365     Document Type: Review

References (310)

1. Inhibition of coronary artery atherosclerosis: Lack of effect of added progesterone
2. Medroxyprogesterone acetate antaonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis
3. Estrogen attenuates endothelin-1 production by bovine endothelial cells via estrogen receptor
4. Estrogen inhibits cuff-induced intimal thickening of rat femoral artery: Effects on migration and proliferation of vascular smooth muscle cells
5. Basic fibroblast growth factor release by human coronary artery endothelial cells is enhanced by matrix proteins, 17beta-estradiol, and a PKC signaling pathway
6. Estrogen metabolism and excretion in Oriental and Caucasian women
7. Stable over-expression of estrogen receptor-alpha in ECV304 cells inhibits proliferation and levels of secreted endothelin-1 and vascular endothelial growth factor
8. 17β-estradiol inhibits apoptosis of endothelial cells
9. Estrogen action via the cAMP signaling pathway: Stimulation of adenylate cyclase and cAMP-regulated gene transcription
10. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo
11. Estrogen-induced vasoprotection is estrogen receptor dependent. Evidence from the balloon-injury rat carotid artery model
12. Formation, metabolism, and physiologic importance of catecholestrogens
13. Estradiol increases rat aorta endothelium-derived relaxing factor (EDRF) activity without changes in endothelial NO synthase gene expression: Possible role of decreased endothelium-derived super-oxide anion production
14. ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade
15. Estrogen synthesis, estrogen metabolism, and functional estrogen receptors in rat arterial smooth muscle cells in culture
16. 17β-estradiol protects neurons from oxidative stress-induced cell death in vitro
17. Effects of 17β-estradiol on the biosynthesis of collagen in cultured bovine aortic smooth muscle cells
18. Effect of hypocholesterolemic doses of 17α-ethinyl estradiol on cholesterol balance in liver and extrahepatic tissues
19. Immunocytochemical localization of c-myc and c-jun oncoproteins in hamster kidney and estrogen-induced kidney tumors
20. 17β-estradiol reduces vasoconstriction in endothelium-denuded rat aortas through inducible NOS
21. Transforming growth factor β in tissue fibrosis
22. Insulin like growth factor-1 and platelet derived growth factor BB induce directed migration of human arterial smooth muscle cells via signalling pathways that are distinct from those of proliferation
23. Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice
24. Tissue distribution of estrogen receptors alpha (ER-alpha) and beta (ER-beta) mRNA in the midgestational human fetus
25. Evidence for primary and secondary prevention of coronary artery disease in women taking oestrogen replacement therapy
26. Neonatal gonadal hormones and blood pressure in the spontaneously hypertensive rat
27. Effect of estrogen on very low density lipoprotein and low density lipoprotein subclass metabolism in postmenopausal women
28. Differential effects of estrogen in murine lupus: Accleration of glomerulonephritis and amelioration of T cell-mediated lesions
29. Effect of sex hormones on gentamicin-induced nephrotoxicity
30. Stereoisomer-specific inhibition of super-oxide anion-induced rat aortic smooth-muscle cell proliferation by 17β-estradiol is estrogen receptor dependent
31. 2+ mobilization
32. Effects of 17β-estradiol on cytokine-induced endothelial cell adhesion molecule expression
33. Stimulation of prostaglandin cyclooxygenase and prostacyclin synthase activities by estradiol in rat aortic smooth muscle cells
34. Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery
35. Estrogen receptor a mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen
36. Inhibition of myointimal hyperplasia and macrophage infiltration by estradiol in aorta allografts
37. Aldosterone, not estradiol, is the physiological agonist for rapid increases in cAMP in vascular smooth muscle cells
38. 17β-estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease
39. Nitric oxide accounts for dose-dependent estrogen-mediated coronary relaxation after acute estrogen withdrawl
40. Transcriptional regulation of endothelial cell adhesion molecules: NF-κβ and cytokine inducible enhancers
41. Estrogen increases low-density receptor-independent catabolism of apolipoprotein B in hyperlipidemic rabbits
42. Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells
43. Gonadal hormones modulate deoxycorticosterone-salt hypertension in male and female rats
44. Estrogen relaxation of coronary artery smooth muscle is mediated by nitric oxide and cGMP
45. Estrogens modulate bovine vascular endothelial cell permeability and HSP 25 expression concomitantly
46. Increased removal of beta-very low density lipoproteins after ethinyl estradiol is associated with increased mRNA levels for hepatic lipase, lipoprotein lipase and low density lipoprotein receptor in Watanabe hyperlipidemic rabbits
47. Focal and segmental glomerulosclerosis: Analogies to atherosclerosis
48. Independent behavior of rat liver LDL receptor and HMGCoA reductase under estrogen treatment
49. Vasodilator-derived nitric oxide inhibits fetal calf serum and angiotensin II-induced growth of renal arteriolar smooth muscle cells
50. Phytoestrogens inhibit growth and MAP kinase activity in human aortic smooth muscle cells
51. 17β-estradiol, its metabolites and progesterone inhibit cardiac fibroblast growth
52. Estradiol inhibits smooth muscle cell growth in part by activating the cAMP-adenosine pathway
53. Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and MAP kinase activity
54. Methoxyestradiols mediate the antimitogenic effects of estradiol on vascular smooth muscle cells via estrogen receptor-independent mechanisms
55. Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotides and angiotensin 1 receptors
56. Factors controlling growth and matrix production in vascular smooth muscle and glomerular mesangial cells
57. Estrogen and tamoxifen metabolites protect smooth muscle cell membrane phospholipids against peroxidation and inhibit cell growth
58. Vasoactive hormones and renal sclerosis
59. Prevention of fatty streak formation of 17β-estradiol is not mediated by the production of nitric oxide in apolipoprotein E-deficient mice
60. Human estrogen receptor beta-gene structure, chronosomal localisation and expression pattern
61. Modulation of glomerular ECTO-ADPase expression by oestradiol. A histochemical study
62. Estradiol increases cyclic adenosine monophosphate in rat pulmonary vascular smooth muscle cells by a nongenomic mechanism
63. The vascular protective effects of estrogen
64. Early induction of angiotensin I-converting enzyme in rat carotid artery after balloon injury
65. Increased synthesis of aortic collagen and elastin in experimental atherosclerosis: Inhibition by contraceptive steroids
66. Estradiol inhibition of arterial neointimal hyperplasia after balloon injuy
67. Estradiol protects against experimental cardiac transplant atherosclerosis
68. Cardiovascular effects of estrogen: Implications of the discovery of the estrogen receptor subtype β
69. Oestradiol inhibition of vascular myointimal proliferation following immune, chemical and mechanical injury
70. The endogenous oestrogen metabolite 2-methoxyestradiol inhibits angiogenesi and suppresses tumor growth
71. Serum lipids and incidence of coronary heart disease. Findings from the systolic hypertension in the elderly program (SHEP)
72. Estrogen regulation of angiotensin-converting enzyme mRNA
73. Risk of gyneacomastia associtated with cimetidin, omeprazole, and other antinuclear drug
74. Modified LDL-mediated increases inendothelial layer permeability are attenuated with 17 beta-estradiol
75. Nitric oxide generating yasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells
76. Activation of ovalbumin gene by the estrogen receptor involves the fos-jun complex
77. Conjugated equine estrogens inhibit progression of atherosclerosis but have no effect on intimal hyperplasia or arterial remodeling induced by balloon catheter injury in monkeys
78. Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study
79. Effects of sex steroids on plasma total homocysteine levels: A study in transsexual males and females
80. Acute vascular effects of estrogen in post-menopausal women
81. Estradiol induces the calcium-dependent translocation of endothelial nitric oxide synthase
82. Effects and interactions of endothelin-1 and angiotenin-II on matrix protein expression and synthesis and mesangial cell growth
83. Hormone therapy to prevent disease and prolong life in postmenopausal women
84. Human estrogen receptor cDNA: Sequence, expression and homology to v-erb-A
85. Effects of dihydrotestosterone and estradiol on experimental IgA nephroparhy induced by vomitoxin
86. Modulation of glomerular sclerosis and interstitial fibrosis by native and modified lipoproteins
87. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women
88. Inhibition of the protective effects of estrogen by progesterone in experimental atherosclerosis
89. Effect of 17-β estradiol on pre-existing atherosclerotic lesions: Role of the endothelium
90. Localized expression of aromatase in human vascular tissues
91. Estrogen stimulates van Willebrand factor production by cultured endothelial cells
92. The long-term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure
93. Physiological concentrations of 17β-estradiol inhibit the synthesis of nitric oxide synthase in macrophages via a receptor-mediated system
94. Venous thromboembolism and the pill. The WHO technical report on cardiovascular disease and steroid hormone contraception: State-of-the-art
95. Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy
96. Lack of effect on the low density lipoprotein receptor in hamsters treated with 17α-ethinyl estradiol
97. Variant estrogen and progesterone receptor messages in human vascular smooth muscle
98. Estrogen receptors α and β. Prevelance of estrogen receptor β mRNA in human vascular smooth muscle and transcriptional effects
99. The direct antiatherogenic effect of estrogen is present, absent or reversed, depending on the state of the arterial endothelium. A time course study in cholesterol-clamped rabbits
100. Significant reduction of the antiatherogenic effect of estrogen by long-term inhibition of nitric oxide synthesis in cholesterol clamped rabbits
101. Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women
102. Estrogen-induced protooncogene and suppressor gene expression in the hamster kidney: Significance for estrogen carcinogenesis
103. Sex steroids: Physiology and metabolism
104. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
105. Circulating adhesion molecules VCAM-1, ICAM-1 and E-selectin in carotid athero-sclerosis and incident coronary heart disease cases. The atherosclerosis risk in communities (ARIC) study
106. Characterization of the promoter for the vascular cell adhesion molecule-1 (VCAM-1)
107. Estrogen inhibits the vascular injury response in estrogen receptor α deficient mice
108. Coupling of dual signaling pathways: Epidermal growth factor action involves estrogen receptor
109. Inhibitory effects of female sex hormones on urinary stone formation in rats
110. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrate/nitrite) levels in postmenopausal women substituted with 17β-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate
111. Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis
112. Effects of estradiol on circulating P-selectin
113. Disruption of estrogen receptor gene prevents 17β-estradiol-induced angiogenesis in transgenic mice
114. Ovariectomy decreases plasma triglyceride levels and both prevents and alleviates glomerular disease in uninephrectomized female analbuminemic rats
115. Estrogen upregulates cyclooxygenase-1 gene expression in ovine fetal pulmonary artery endothelium
116. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells
117. Growth factor activation of the estrogen receptor in vascular cells occurs via a mitogen-activated protein kinase-independent pathway
118. Estrogen inhibits the vascular injury response in estrogen receptor beta-deficient female mice
119. Expression of inducible-NOS in human glomerulo-nephritis: The possible source infiltrating monocytes/macrophages
120. A new actor in the estrogen receptor drama - Enter ER-β
121. Effect of 17beta-estradiol on cytokine-induced nitric oxide production in rat isolated aorta
122. 17β-estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine
123. Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor alpha localized in caveolae
124. Estrogen stimulates delayed mitogen-activated protein kinase activity in human endothelial cells via an autocrine loop that involves basic fibroblast growth factor
125. Autonomous derivatives of estrogen-induced renal carcinomas, and spontaneous renal tumors in Syrian hamsters
126. Non-genomic mechanism of 17β-oestradiol-induced inhibition of contraction in mammalian vascular smooth muscle
127. Vascular effects of estrogen and vitamin E therapies in postmenopausal women
128. Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women
129. Estradiol attenuates directed migration of vascular smooth muscle cells in vitro
130. Insights from the study of animals lacking functional estrogen receptor
131. Estrogen receptor gene disruption: Molecular characterization and experimental and clinical phenotypes
132. Estradiol accelerates functional endothelial recovery after arterial injury
133. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β
134. Cloning of a novel receptor expressed in rat prostate and ovary
135. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β
136. Effect of estrogen and progesterone on the expression of hepatic and extrahepatic sterol 27-hydroxylase in baboons (Papio sp)
137. Effects of sex hormones on mesangial cell proliferation and collagen synthesis
138. VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries
139. Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium
140. Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney
141. 1 type IV collagen gene transcription is mediated by TGF-β and inhibited by estradiol
142. Gonadectomy and hormonal replacement changes systolic blood pressure and ventricular myosin isoenzyme pattern of spontaneously hypertensive rats
143. Patterns of coronary heart disease morbidity and mortality in the sexes: A 26-year follow-up of the Framingham population
144. Medroxyprogesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery
145. Estrogen inhibits vascular smooth muscle cell-dependent adventitial fibroblast migration in vitro
146. Overexpression and amplication of c-myc in Syrian hamster kidney during estrogen carcinogen esis: A probable critical role in neoplastic transformation
147. Induction of cathepsin D protein during estrogen carcinogenesis: Possible role in estrogen-mediated kidney tubular cell damage
148. 4-Hydroxylation of estrogens as marker of human mammary tumors
149. Increased expression of estrogen receptor B mRNA in male blood vessels after vascular injury
150. Behavioral stress responses in premenopausal and post-menopausal women and the effects of estrogen
151. An investigation of the relationship between estrogen, estrogen metabolites and blood cholesterol levels in ovariectomized rats
152. Estrogen and the risk of coagulopathy
153. Inhibition of transplant coronary arteriosclerosis in rabbits by chronic estradiol treatment is associated with abolition of MHC class II antigen expression
154. Upregulation of estrogen receptor-α expression in rabbit cardiac allograft
155. Estradiol 17β represses insulin-like growth factor I receptor expression in smooth muscle cells from rabbit cardiac recipients
156. Estrogen effects on insulin-like growth factor-I (IGF-I) induced cell proliferation and IGF-I expression in native and allograft vessels
157. Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta
158. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT
159. Hyperhomocyst(e)inemia and the prevelance of atherosclerotic vascular disease in patients with end-stage renal disease
160. Preliminary characterization and partial purification of rat uterine nuclear type II binding sites
161. Bioflavonoid interaction with rat uterine type II binding sites and cell growth inhibition
162. Concentration dependence of prooxidant and antioxidant properties of catechol estrogens
163. In vitro inhibition by estrogens of the oxidative modifications of human lipoproteins
164. P450 enzyme of estrogen metabolism
165. Effects of estradiol on very low density lipoprotein receptor mRNA levels in rabbit heart
166. The protective effects of estrogen on the cardiovascular system
167. Tumor necrosis factor-alpha and lipopolysaccharide induce apoptotic cell death in bovine glomerular endothelial cells
168. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells
169. 17β-estradiol stimulates prostacyclin, but not endothelin-1, production in human vascular endothelial cells
170. Impact of gender on the renal response to angiotensin II
171. Progesterone inhibits inducible nitric oxide synthase gene expression and nitric oxide production in murine macrophages
172. An estrogen receptor-selective corepressor: Cloning and characterization
173. Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model
174. Human leukemia inhibitory factor upregulates LDL receptors on liver cells and decreases serum cholesterol in the cholesterol-fed rabbits
175. Human leukemia inhibitory factor inhibits development of experimental atherosclerosis
176. Estrogen and progesterone inhibit vascular smooth muscle proliferation
177. Oestrogen and progesterone inhibit the stimulated production of endothelin-1
178. ER-β: Identification and characterization of a novel human estrogen receptor
179. Local administration of estrogen inhibits transplant arteriosclerosis in rat aorta accelerated by tropical exposure to IGF-1
180. Sex hormones and gender-related differences: Their influence on chronic renal allograft rejection
181. Gender differences in renal growth and function after uninephrectomy in adult rats
182. Sex differences in renal hemodynamics in rats
183. Mechanism of the rapid effect of 17beta-estradiol on medial amygdala neurons
184. For the atherosclerosis risk in communities study investigators: Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women
185. Estradiol-17β regulates the induction of VCAM-1 mRNA expression by interleukin-1β in human umbilical vein endothelial cells
186. 2+ currents in aortic smooth muscle cells
187. Effect of 17beta-estradiol on inhibition of platelet aggregation in vitro is mediated by an increase in NO synthesis
188. Nitric oxide mediates immunologic injury to kidney mesangium in experimental glomerulonephritis
189. Effect of 17β-estradiol in hypercholesterolemic rabbits with sever endothelial dysfunction
190. Estradiol inhibits leukocyte adhesion and transendothelial migration in rabbits in vivo. Possible mechanisms for gender differences in atherosclerosis
191. Protective effect of 17beta-estradiol against cytotoxicity of minimally oxidized LDL to cultured bovine aortic endothelial cells
192. Effect of gender on the progression of nondiabetic renal disease: A meta-analysis
193. Sex hormones and renal nitric oxide synthases
194. Estradiol inhibits mesangial cell mediated oxidation of low-density lipoprotein
195. Estradiol reverses AII- and endothelin-stimulated mesangial cell COL4A1 gene transcription by antagonizing autocrine TGF-β1
196. Estradiol suppresses mesangial cell type I collagen synthesis via activation of the MAP kinase cascade
197. Long-term estrogen therapy improves vascular function in male to female transsexuals
198. 1 receptor gene expression in vitro and in vivo
199. Anti-proliferative effect of 2-methoxyestradiol on cultured smooth muscle cells from rabbit aorta
200. Amelioration of ischemia- and reperfusion-induced myocardial injury by 17β-estradiol: Role of nitric oxide and calcium- activated potassium channels
201. Effects of 17β-estradiol and progesterone on migration of human monocytic THP-1 cells stimulated by minimally oxidized low density lipoproteins in vitro
202. Expression of estrogen receptor β in rat bone
203. Hormones and vasoprotection
204. Sexually dimorphic response of the balloon-injured rat carotid artery to hormone treatment
205. Sex hormones and the vasculature
206. VEGF (165) mediates glomerular endothelial repair
207. Estrogen increases renal oxytocin receptor gene expression
208. Differential ligand activation of estrogen receptor ERalpha and ERbeta at AP 1 sites
209. Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding
210. Importance of estrogen receptors in hepatic LDL receptor regulation
211. Macrophage oxidation of low density liporpotein generates a modified form recognized by the scavenger receptor
212. Inhibitory action of acute estradiol treatment on the activity and quantity of tyrosine hydroxylase in the median eminence of ovariectomized rats
213. Differential activation by xenoestrogens of ER alpha and ER beta when linked to different response elements
214. Estradiol suppresses MCP-1 expression in vivo: Implications for atherosclerosis
215. 2, a functional variant of estrogen receptor beta expressed in normal rat tissues
216. Estradiol increases and anti-estrogens antagonize the growth factor induced activator protein-1 activity in MCF7 breast cancer cells without affecting c-fos and c-jun synthesis
217. Endometrial cell calcium and oestradiol action
218. Hormone replacement therapy and serum angiotensin-converting enzyme activity in postmenopausal women
219. Oral estradiol-17β raises the level of plasma high-density lipoprotein in menopausal women by slowing down its clearance rate
220. Gender differences in the renal nitric oxide (NO) system: Dissociation between expression of endothelial NO synthase and renal hemodynamic response to NO synthase inhibition
221. Synthesis and regulation of leukaemia inhibitory factor in cultured bovine oviduct cells by hormones
222. Conjugated estrogens acutely abolish abnormal cold-induced coronary vasoconstriction in male cardiac allografts
223. The inhibition of low-density lipoprotein oxidation by 17β-estradiol
224. Short-term effects of transdermal estrogen replacement therapy on coronary vascular reactivity in postmenopausal women with angia pectoris and normal results on coronary angiograms
225. Early menopause and risk of myocardial infarction
226. Female sex hormone and nephropathy in cohen diabetes rat (genetically selected sucrose fed)
227. The pathogenesis of atherosclerosis: A perspective for the 1990s
228. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17β-estradiol and norethisterone acetate: A two year follow-up study
229. Estradiol inhibits mitogen induced proliferation and migration of human aortic smooth muscle cells: Implications for cardiovascular disease in women
230. Cellular and biochemical mechanisms by which environmental estrogens may influence the reproduction function
231. Aryl hydrocarbon receptor-mediated signal transduction
232. Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta: Gender difference and effect of estrogen receptor gene disruption
233. 2+ channels in smmoth muscle cells
234. + channels
235. Human vascular endothelial cells contain membrane binding sites for estradiol which mediate rapid intracellular signaling
236. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women
237. Modulation of gene expression and endocrine response pathways by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds
238. Effects of estrogen on nitric oxide synthase expression in rat aorta allograft and smooth muscle cells
239. Growth factors and transplant vascular disease
240. Estrogen replacement therapy with its physiological dose does not eliminate the aggravating effect of ovariectomy on glomerular injury in hypercholesterolemic female Imai rats
241. Association of hormone replacement therapy with hemostatic and other cardiovascular risk factors: The FINRISK Hemostasis Study
242. Ah receptor signaling pathways
243. Oestrogen and endothelial cell angiogenic activity
244. Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women
245. Aging, menopause and free radicals
246. Effect of estradiol metabolites on prostacyclin synthesis in human endothelial cell cultures
247. Ovarian ablation alone promotes aortic hyperplasia and accumulation of fibroblast growth factor
248. Estrogen replacement inhibits hyperplasia and the accumulation and effects of transforming growth factor beta 1
249. Effect of ovariectomy and estrogen replacement on cardiovascular disease in heart failure SHHF/Mac-facp rats
250. The emerging role of transforming growth factor-β in kidney diseases
251. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action
252. Antioxidant protection of LDL by physiological concentrations of 17β-estradiol requirement for estradiol modification
253. Estradiol suppresses type I collagen synthesis by mesangial cells via activation of AP-1
254. Estradiol reverses TGF-β 1 stimulated type IV collagen gene transcription in murine mesangial cells
255. The impact of gender on the progression of chronic renal disease
256. Selective estrogen receptor modulators: Different actions on vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells
257. Age and sex medulate renal expression of SGP-2 and transglutaminase and apoptosis of splenocytes, thymocytes, and macrophages
258. Estrogen-receptor-mediated inhibition of human endothelial cell apoptosis. Estradiol as a survival factor
259. In vivo regulation of low-density lipoprotein receptors by estrogen differs at the post-transcriptional level in rat and mouse
260. Estrogen up-regulates apolipoprotein E (Apo E) gene expression by increasing ApoE mRNA in the translating pool via the estrogen receptor alpha-mediated pathway
261. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
262. Cell surface estrogen receptors mediate calcium-dependent nitric oxide release in human endothelia
263. Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-Kβ and C/EBP beta
264. Estrogen worsens incipient hypertriglyceridemic glomerular injury in the obese Zucker rats
265. End-stage renal failure appears earlier in men than in women with polycystic kidney disease
266. Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man
267. Endothelial dysfunction in a man with disruptive mutation in oestrogen-receptor gene
268. Effect of 17β-estradiol on metabolism of acetylated low-density lipoprotein by THP-1 macrophages in culture
269. Estrogen replacement and coronary artery disease
270. Estrogen inhibits the response-to-injury in a mouse carotid artery model
271. Effects of 17β-estradiol and progesterone on the adhesion of human monocytic THP-1 cells to human female endothelial cells exposed to minimally oxidized LDL
272. 17β-estradiol increases VEGF receptor-2 and promotes DANN synthesis in retinal microvascular endothelial cells
273. VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DANN synthesis in primary endothelial cells
274. In vivo regulation of apolipoprotein A-1 gene expression by estradiol and testosterone occurs by different mechansims in inbred strains of mice
275. Effects on haemostasis of hormone replacement therapy with transdermal estradiol and oral sequential medroxy-progesterone acetate: A one-year, double-blind, placebo-controlled study
276. Effects of estrogen or estrogen progestin regimens on heart disease risk factors in postmenopausal women
277. Cloning, chromosomal localization, and functional analysis of the murine estrogen receptor β
278. Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis
279. 2-Methoxyestradiol, an endogenous metabolite of estrogen, enhances apoptosis and beta-galactosidase expression in vascular endothelial cells
280. Acute activation of Maxi-K channels (hSlo) by estradiol binding to the beta subunit
281. Oestrogenic compounds modulate cytokine-induced nitric-oxide production in mouse osteoblast like cells
282. Stimulation of TPA-responsve element activity by a cooperative action of insulin and estrogen in human breast cancer cells
283. The effect of sequential three-monthly hormone replacement therapy on several cardiovascular risk estimators in postmenopausal women
284. Dose effect and pharmacokinetics of estrogens given to correct bleeding time in uremia
285. Effects of short term hormone replacement therapies on low density lipoprotein metabolism in cynomolgus monkeys
286. Esterified estrogens with and without methyltestosterone decrease arterial LDL metabolism in cynomolgus monkeys
287. Homocysteine-induced endothelial cell injury in vitro: A model for the study of vascular injury
288. 17β-estradiol reduces glycooxidative damage in the artery wall
289. Effects of postmenopausal hormone replacement with oral and transdermal estrogen on high density lipoprotein metabolism
290. Modulation of growth factor action. Implications for the treatment of cardiovascular diseases
291. Induction by estrogens of lipid peroxidation and lipid peroxide-derived malnoa dehyde-DNA adducts in male syrian hamsters: Role of lipid peroxidation in estrogen-induced kidney carcinogenesis
292. Molecular effects of genistein on estrogen receptor mediated pathways
293. Vascular endothelial growth factor and heparin in a biologic glue promotes human aortic endothelial cell proliferation with aortic smooth muscle cell inhibition
294. Induction of calcium-dependent nitric oxide synthases by sex hormones
295. + channels
296. Cardiovascular health and disease in women
297. Estrogen relaxes coronary arteries by opening BKCa channels through a cGMP-dependent mechanism
298. Short term administration of estrogen and vascular responses of atherosclerotic coronary arteries
299. Contrasting effects of conjugated estrogens and tamoxifen on dilator responses of atherosclerotic epicardial coronary arteries in non-human primates
300. 17β-oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells
301. 2, and expression of adhesion molecules by endothelial cells
302. Effects of combined estrogen and progestin administration on plasma lipoprotein metabolism in postmenopausal women
303. Estradiol and its metabolites differentially induce NO synthesis by human glomerular endothelial cells and inhibit glomerular mesangial cell growth
304. Expression of transforming growth factor isoforms in human glomerular disease
305. Postmenopausal hormonal replacement decreases plasma levels of endothelin-1
306. 17β-estradiol decreases nitric oxide synthase II synthesis in vascular smooth muscle cells
307. Systemic and histopathologic changes in Beagle dogs after chronic daily oral administration of synthetic (ethinyl estradiol) or natural (estradiol) estrogens, with special reference to the kidney and thyroid
308. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis?
309. L-Arginine, the precursor of nitric oxide abolished the effects of estrogens on bleeding time in experimental uremia